⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

ARWR News

Arrowhead Research Corporation

Arrowhead Pharmaceuticals Requests Regulatory Clearance to Initiate Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies